AmerisourceBergen to pay $625M to settle fraud charges

The settlement agreed to by AmerisourceBergen resolves charges tied to the improper repackaging of cancer drugs by a subsidiary.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.